Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013646646> ?p ?o ?g. }
- W3013646646 endingPage "3970" @default.
- W3013646646 startingPage "3947" @default.
- W3013646646 abstract "PURPOSE To provide guidance to clinicians regarding the use of systemic therapy for melanoma. METHODS ASCO convened an Expert Panel and conducted a systematic review of the literature. RESULTS A systematic review, one meta-analysis, and 34 additional randomized trials were identified. The published studies included a wide range of systemic therapies in cutaneous and noncutaneous melanoma. RECOMMENDATIONS In the adjuvant setting, nivolumab or pembrolizumab should be offered to patients with resected stage IIIA/B/C/D BRAF wild-type cutaneous melanoma, while either of those two agents or the combination of dabrafenib and trametinib should be offered in BRAF-mutant disease. No recommendation could be made for or against the use of neoadjuvant therapy in cutaneous melanoma. In the unresectable/metastatic setting, ipilimumab plus nivolumab, nivolumab alone, or pembrolizumab alone should be offered to patients with BRAF wild-type cutaneous melanoma, while those three regimens or combination BRAF/MEK inhibitor therapy with dabrafenib/trametinib, encorafenib/binimetinib, or vemurafenib/cobimetinib should be offered in BRAF-mutant disease. Patients with mucosal melanoma may be offered the same therapies recommended for cutaneous melanoma. No recommendation could be made for or against specific therapy for uveal melanoma. Additional information is available at www.asco.org/melanoma-guidelines ." @default.
- W3013646646 created "2020-04-03" @default.
- W3013646646 creator A5003976494 @default.
- W3013646646 creator A5007239425 @default.
- W3013646646 creator A5012911914 @default.
- W3013646646 creator A5029398339 @default.
- W3013646646 creator A5034103357 @default.
- W3013646646 creator A5037195553 @default.
- W3013646646 creator A5039363773 @default.
- W3013646646 creator A5039939240 @default.
- W3013646646 creator A5052526230 @default.
- W3013646646 creator A5056132643 @default.
- W3013646646 creator A5056264426 @default.
- W3013646646 creator A5057402683 @default.
- W3013646646 creator A5058902095 @default.
- W3013646646 creator A5061209536 @default.
- W3013646646 creator A5061683749 @default.
- W3013646646 creator A5065243976 @default.
- W3013646646 creator A5073287253 @default.
- W3013646646 creator A5075441317 @default.
- W3013646646 creator A5075871926 @default.
- W3013646646 creator A5077044333 @default.
- W3013646646 creator A5077265672 @default.
- W3013646646 creator A5080404941 @default.
- W3013646646 creator A5087113555 @default.
- W3013646646 creator A5087309962 @default.
- W3013646646 creator A5088042471 @default.
- W3013646646 creator A5089367909 @default.
- W3013646646 creator A5089516753 @default.
- W3013646646 creator A5090727184 @default.
- W3013646646 creator A5091860403 @default.
- W3013646646 date "2020-11-20" @default.
- W3013646646 modified "2023-10-11" @default.
- W3013646646 title "Systemic Therapy for Melanoma: ASCO Guideline" @default.
- W3013646646 cites W1809627231 @default.
- W3013646646 cites W1965370740 @default.
- W3013646646 cites W1971941564 @default.
- W3013646646 cites W2008150857 @default.
- W3013646646 cites W2014975424 @default.
- W3013646646 cites W2038325530 @default.
- W3013646646 cites W2038434969 @default.
- W3013646646 cites W2054310049 @default.
- W3013646646 cites W2055118638 @default.
- W3013646646 cites W2055901890 @default.
- W3013646646 cites W2061597055 @default.
- W3013646646 cites W2063717508 @default.
- W3013646646 cites W2070023785 @default.
- W3013646646 cites W2070825440 @default.
- W3013646646 cites W2075868042 @default.
- W3013646646 cites W2095623039 @default.
- W3013646646 cites W2096870516 @default.
- W3013646646 cites W2097691839 @default.
- W3013646646 cites W2097995306 @default.
- W3013646646 cites W2098492855 @default.
- W3013646646 cites W2103152130 @default.
- W3013646646 cites W2109274792 @default.
- W3013646646 cites W2109536183 @default.
- W3013646646 cites W2112121482 @default.
- W3013646646 cites W2112410464 @default.
- W3013646646 cites W2115111964 @default.
- W3013646646 cites W2115369775 @default.
- W3013646646 cites W2120415677 @default.
- W3013646646 cites W2121545342 @default.
- W3013646646 cites W2123363005 @default.
- W3013646646 cites W2123628301 @default.
- W3013646646 cites W2129176838 @default.
- W3013646646 cites W2133910360 @default.
- W3013646646 cites W2136746908 @default.
- W3013646646 cites W2136919572 @default.
- W3013646646 cites W2140974115 @default.
- W3013646646 cites W2144724678 @default.
- W3013646646 cites W2152897456 @default.
- W3013646646 cites W2156078931 @default.
- W3013646646 cites W2160766792 @default.
- W3013646646 cites W2164130643 @default.
- W3013646646 cites W2166662937 @default.
- W3013646646 cites W2170065082 @default.
- W3013646646 cites W2170915815 @default.
- W3013646646 cites W2171301878 @default.
- W3013646646 cites W2226896830 @default.
- W3013646646 cites W2265287921 @default.
- W3013646646 cites W2269457085 @default.
- W3013646646 cites W2284583894 @default.
- W3013646646 cites W2346188454 @default.
- W3013646646 cites W2401249661 @default.
- W3013646646 cites W2416115344 @default.
- W3013646646 cites W2473956396 @default.
- W3013646646 cites W2494135329 @default.
- W3013646646 cites W2525217971 @default.
- W3013646646 cites W2529373149 @default.
- W3013646646 cites W2549006299 @default.
- W3013646646 cites W2555619826 @default.
- W3013646646 cites W2560525874 @default.
- W3013646646 cites W2561969821 @default.
- W3013646646 cites W2583263803 @default.
- W3013646646 cites W2585271320 @default.
- W3013646646 cites W2594529508 @default.
- W3013646646 cites W2603690292 @default.